Structure of pathological TDP-43 filaments from ALS with FTLD

被引:0
|
作者
Diana Arseni
Masato Hasegawa
Alexey G. Murzin
Fuyuki Kametani
Makoto Arai
Mari Yoshida
Benjamin Ryskeldi-Falcon
机构
[1] MRC Laboratory of Molecular Biology,Department of Brain and Neurosciences
[2] Tokyo Metropolitan Institute of Medical Science,Department of Psychiatry and Behavioural Sciences
[3] Tokyo Metropolitan Institute of Medical Science,Institute for Medical Science of Aging
[4] Aichi Medical University,undefined
来源
Nature | 2022年 / 601卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The abnormal aggregation of TAR DNA-binding protein 43 kDa (TDP-43) in neurons and glia is the defining pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and multiple forms of frontotemporal lobar degeneration (FTLD)1,2. It is also common in other diseases, including Alzheimer’s and Parkinson’s. No disease-modifying therapies exist for these conditions and early diagnosis is not possible. The structures of pathological TDP-43 aggregates are unknown. Here we used cryo-electron microscopy to determine the structures of aggregated TDP-43 in the frontal and motor cortices of an individual who had ALS with FTLD and from the frontal cortex of a second individual with the same diagnosis. An identical amyloid-like filament structure comprising a single protofilament was found in both brain regions and individuals. The ordered filament core spans residues 282–360 in the TDP-43 low-complexity domain and adopts a previously undescribed double-spiral-shaped fold, which shows no similarity to those of TDP-43 filaments formed in vitro3,4. An abundance of glycine and neutral polar residues facilitates numerous turns and restricts β-strand length, which results in an absence of β-sheet stacking that is associated with cross-β amyloid structure. An uneven distribution of residues gives rise to structurally and chemically distinct surfaces that face external densities and suggest possible ligand-binding sites. This work enhances our understanding of the molecular pathogenesis of ALS and FTLD and informs the development of diagnostic and therapeutic agents that target aggregated TDP-43.
引用
收藏
页码:139 / 143
页数:4
相关论文
共 50 条
  • [41] ALS mutant SOD1 affects pathological modifications of TDP-43
    Jeon, G. S.
    Ahn, S. H.
    Im, S. Y.
    Sung, J. -J.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 220 - 220
  • [42] Differential detection of TDP-43 in FTLD-TDP Type C using antibodies targeting distinct TDP-43 phosphorylated sites
    Cracco, L.
    Jacobsen, M.
    Hallinan, G.
    Garringer, H.
    Buratti, E.
    Ghetti, B.
    Newell, K.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 437 - 437
  • [43] Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS
    Jacqueline C Mitchell
    Remy Constable
    Eva So
    Caroline Vance
    Emma Scotter
    Leanne Glover
    Tibor Hortobagyi
    Eveline S. Arnold
    Shuo-Chien Ling
    Melissa McAlonis
    Sandrine Da Cruz
    Magda Polymenidou
    Lino Tessarolo
    Don W Cleveland
    Christopher E Shaw
    Acta Neuropathologica Communications, 3
  • [44] Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS
    Mitchell, Jacqueline C.
    Constable, Remy
    So, Eva
    Vance, Caroline
    Scotter, Emma
    Glover, Leanne
    Hortobagyi, Tibor
    Arnold, Eveline S.
    Ling, Shuo-Chien
    McAlonis, Melissa
    Da Cruz, Sandrine
    Polymenidou, Magda
    Tessarolo, Lino
    Cleveland, Don W.
    Shaw, Christopher E.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2015, 3 : 36
  • [45] Reappraisal of TDP-43 pathology in FTLD-U subtypes
    Mackenzie, Ian R.
    Neumann, Manuela
    ACTA NEUROPATHOLOGICA, 2017, 134 (01) : 79 - 96
  • [46] Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
    Manuela Neumann
    Petra Frick
    Francesca Paron
    Jonas Kosten
    Emanuele Buratti
    Ian R. Mackenzie
    Acta Neuropathologica, 2020, 140 : 645 - 658
  • [47] ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons
    Han, Jeong-Ho
    Yu, Tae-Hoon
    Ryu, Hyun-Hee
    Jun, Mi-Hee
    Ban, Byung-Kwan
    Jang, Deok-Jin
    Lee, Jin-A
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (13) : 1998 - 2005
  • [48] TDP-43 cytoplasmic inclusion formation in C9orf72-associated FTLD/ALS
    Lee, Samuel
    Asress, Seneshaw
    Hales, Chadwick
    Vizcarra, Juan
    Gutman, David
    Gearing, Marla
    Chin, Lih-Shen
    Li, Lian
    Glass, Jonathan
    NEUROLOGY, 2019, 92 (15)
  • [49] Reappraisal of TDP-43 pathology in FTLD-U subtypes
    Ian R. Mackenzie
    Manuela Neumann
    Acta Neuropathologica, 2017, 134 : 79 - 96
  • [50] Tau negative FTLD without abnormal TDP-43 immunoreactivity
    Josephs, Keith A.
    Stroh, Alex
    Dickson, Dennis W.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (05): : 513 - 513